CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 4.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,587,049 | +18.1% | 1,018,091 | +13.0% | 1.85% | -4.8% |
| Q2 2023 | $5,575,475 | +111.7% | 900,723 | +31.7% | 1.95% | +124.1% |
| Q1 2023 | $2,633,889 | +84.6% | 684,127 | +48.6% | 0.87% | +55.2% |
| Q4 2022 | $1,427,017 | +46.4% | 460,328 | +89.8% | 0.56% | +105.9% |
| Q3 2022 | $975,000 | +66.4% | 242,517 | +271.5% | 0.27% | +189.4% |
| Q1 2022 | $586,000 | -87.6% | 65,282 | -84.4% | 0.09% | -94.5% |
| Q4 2021 | $4,720,000 | +39.1% | 419,144 | +106.3% | 1.71% | +100.0% |
| Q3 2021 | $3,393,000 | +128.2% | 203,183 | +203.5% | 0.86% | +61.1% |
| Q2 2021 | $1,487,000 | – | 66,957 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |